Advanced or Metastatic Solid Tumors Active Not Recruiting Phase 1 / 2 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0034454 (Advanced or Metastatic Solid Tumors)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01928394A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid TumorsTreatment